Clinical Trials Directory

Trials / Completed

CompletedNCT05527119

Phenotyping and Genotyping of Duffy Antigen

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Malaria remains the world's leading parasitic endemic. Almost half of the world's population lives in endemic areas. Many at-risk people in African countries remain without access to malaria control. Malaria kills approximately 400,000 people each year, most of whom are children under the age of 5 in Africa. Since 2005, an increasing number of Plasmodium vivax infections have been observed in Duffy-negative populations in South America and Africa, calling into question the essential role of the PvDBP-DARC interaction. The objective of the investigators is therefore to study and understand the invasion pathways used by Plasmodium vivax in Duffy-negative subjects.

Conditions

Timeline

Start date
2022-03-11
Primary completion
2023-07-11
Completion
2023-09-11
First posted
2022-09-02
Last updated
2023-11-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05527119. Inclusion in this directory is not an endorsement.